Glucose tolerance test
|
phenotype |
|
Laboratory Procedure
|
17
|
28
|
0.100 |
None |
1.000 |
2 |
3
|
2010 |
2018 |
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET
|
disease |
|
Disease or Syndrome
|
1
|
5
|
0.700 |
None |
1.000 |
2 |
5
|
2016 |
2018 |
Lean body mass
|
phenotype |
|
Clinical Attribute
|
144
|
211
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Breast size
|
phenotype |
|
Finding
|
16
|
38
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Fasting blood glucose measurement
|
phenotype |
|
Laboratory Procedure
|
96
|
212
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Severe hypoglycaemia
|
disease |
|
Disease or Syndrome
|
36
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2013 |
2013 |
Neurofibrillary degeneration (morphologic abnormality)
|
phenotype |
|
Cell or Molecular Dysfunction
|
21
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormal male sexual function
|
disease |
|
Mental or Behavioral Dysfunction
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Female sexual dysfunction
|
disease |
|
Mental or Behavioral Dysfunction
|
22
|
3
|
0.100 |
None |
|
0 |
|
|
|
Male sexual dysfunction
|
disease |
|
Disease or Syndrome
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Gait imbalance
|
phenotype |
|
Finding
|
57
|
24
|
0.100 |
None |
|
0 |
|
|
|
Agitation, CTCAE 3.0
|
phenotype |
|
Finding
|
87
|
|
0.100 |
None |
|
0 |
|
|
|
Cerebral cortical atrophy
|
disease |
|
Disease or Syndrome
|
271
|
13
|
0.100 |
None |
|
0 |
|
|
|
Agitation, CTCAE 5.0
|
phenotype |
|
Finding
|
87
|
|
0.100 |
None |
|
0 |
|
|
|
Spasticity, CTCAE
|
phenotype |
|
Finding
|
477
|
|
0.100 |
None |
|
0 |
|
|
|
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.100 |
None |
|
0 |
|
|
|
Impulsive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
276
|
69
|
0.100 |
None |
|
0 |
|
|
|
Apathy
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
83
|
9
|
0.100 |
None |
|
0 |
|
|
|
Reduced concentration span
|
phenotype |
Behavior and Behavior Mechanisms
|
Finding
|
77
|
2
|
0.100 |
None |
|
0 |
|
|
|
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Mental deterioration
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
508
|
121
|
0.110 |
None |
1.000 |
1 |
|
2016 |
2016 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1719
|
297
|
0.100 |
None |
|
0 |
|
|
|